Stay updated on Nab-sirolimus in Brain Cancer Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.

Latest updates to the Nab-sirolimus in Brain Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6, indicating a minor update to the page's backend/format. There are no visible changes to the study details, eligibility criteria, or results based on the provided changes.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision has been updated from v3.6.4 to v3.6.5, indicating a small internal update to the page's revision history.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.6.4 was added, replacing v3.6.3, indicating a deployment update to the page.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a new build of the page. This is a minor version change that does not alter the study data or displayed details.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, indicating an internal update to the site. No study information or user actions are affected by this change.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page now shows 'No longer looking for participants', indicating recruitment has closed, and adds new sections for user guidance such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The header 'Intervention / Treatment' was replaced by 'Intervention/Treatment', and the footer revision note updated to 'Revision: v3.6.0'.SummaryDifference0.4%

Stay in the know with updates to Nab-sirolimus in Brain Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.